Lymph
Burkitt Lymphoma
search
Burkitt Lymphoma
, Burkitt's Lymphoma
See Also
Non-Hodgkin's Lymphoma
Pathophysiology
Aggressive mature B-Cell
Non-Hodgkin's Lymphoma
with rapid proliferation
Myelocytomatosis (MYC)
Oncogene
translocation triggers dysregulated cell growth
All forms of
Types
Sporadic
Most common in North America
Represents 30-50% of
Non-Hodgkin's Lymphoma
in children (esp. boys age 10-12 years)
Incidence
: 3-4 per Million children per year in U.S.
Predilection for ileocecal valve region
EBV association is uncommon (<20%)
Endemic
Most common in equatorial Africa and parts of Papua New Guinea (central africa)
More than 95% cases are associated with Epstein-Barr-
Virus
(EBV) positive (
Mononucleosis
)
EBV Is thought to be a
Cofact
or in malignant transformation (chromosomal arm translocation,
Oncogene
)
Immunodeficiency
-Associated
Most commonly associated with HIV/
AIDS
or post-organ transplant status
May be EBV associated in up to 30-40% of patients
Findings
Sporadic Burkitt Lymphoma
Gastrointestinal symptoms and signs (most common)
Abdominal Pain
Abdominal Distention
Nausea
and
Vomiting
Gastrointestinal Bleeding
Abdominal mass (may be palpable)
B Symptoms (constitutional)
Fever
Night Sweats
Weight loss
Labs
Complete Blood Count
Comprehensive Metabolic Panel
Coagulation tests
Markers of high tumor burden (risk for
Tumor Lysis Syndrome
)
Lactate Dehydrogenase
(LDH) increased
Uric Acid
increased
Diagnosis
Biopsy with histopathology and cytogenetics (including MYC translocation)
Imaging
Abdominal Ultrasound
CT Abdomen
Differential Diagnosis
Sporadic Burkitt Lymphoma
Acute Abdominal Pain
Acute Appendicitis
Gastroenteritis
Intussusception
Abdominal mass or malignancy
Wilms Tumor
Neuroblastoma
Blood malignancy
Other types of
Non-Hodgkin Lymphoma
Management
Sporadic Burkitt Lymphoma
Acute Abdominal Pain
presentation management (e.g. surgery,
Antibiotic
s)
Small Bowel Obstruction
Intussusception
Bowel
perforation
Tumor Lysis Syndrome
prevention
See
Tumor Lysis Syndrome
Aggressive hydration
Electrolyte
correction (
Hyperkalemia
,
Hypocalcemia
,
Hyperphosphatemia
)
Hyperuricemia
management (e.g. Rasburicase,
Allopurinol
)
Chemotherapy
Highly responsive to short-course, intensive multi-agent
Chemotherapy
Complications
Small Bowel Obstruction
or
Intussusception
(with tumor as lead point in sporadic type)
Bowel
perforation
Tumor Lysis Syndrome
Prognosis
Cure rates approach 85-90% with early diagnosis and aggressive treatment
Poor prognostic factors
Advanced disease
Delayed diagnosis
Bulky tumor burden
Resources
Burkitt Lymphoma (Stat Pearls)
https://www.ncbi.nlm.nih.gov/books/NBK538148/
References
Andriescu, Yen and Whitaker (2026) Crit Dec Emerg Med 40(10): 16-7
Pagano (2009) Mediterr J Hematol Infect Dis 1(2):e2009030 +PMID: 21416007 [PubMed]
Type your search phrase here